BioMark Diagnostics, Inc.

Recent News

  • Bio Stream Diagnostics Inc. Selected for CDL Rapid Response Innovation Program

    Vancouver, British Columbia--(Newsfile Corp. - June 16, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that its affiliated company, Bio Stream Diagnostics Inc., was selected to participate in the global academic science and tech startup program Creative Destruction Lab's (CDL) recent dedicated Recovery program. CDL Recovery is designed to help turn science and research work into scalable products and services to address the consequences of the COVID-19 pandemic, in...

    2020-06-16 8:30 AM ET
  • BioMark Diagnostics Inc. Clarifies Prior Disclosure

    Vancouver, British Columbia--(Newsfile Corp. - June 11, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-invasive, and accurate diagnostic solutions which can help detect, monitor and assess cancer early and cost effectively, wishes to include additional information to clarify the disclosures in its news release disseminated by the Company on June 10, 2020 with respect to the formation of Bio Stream Diagnostics Inc., a new company, focused on providing low-cost...

    2020-06-11 5:37 PM ET
  • BioMark Diagnostics Forms New Company, Bio Stream Diagnostics Inc., for '30-Second' COVID-19 Screening

    Vancouver, British Columbia--(Newsfile Corp. - June 10, 2020) - BioMark Diagnostics Inc.(CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-invasive, and accurate diagnostic solutions which can help detect, monitor and assess cancer early and cost effectively, announced today that the Company has partnered with Stream.ML and Merogenomics to form Bio Stream Diagnostics Inc., a new company, focused on providing low-cost COVID-19 detection in less-than-30 seconds. Leveraging Raman spectroscopy and the power of machine learning, the...

    2020-06-10 8:30 AM ET
  • BioMark Announces Filing of Amended and Restated MD&A for the Three and Nine Months Ended December 31, 2019

    Vancouver, British Columbia--(Newsfile Corp. - May 29, 2020) - As a result of a review by the British Columbia Securities Commission, we are issuing the following press release to clarify our disclosure.BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark")announced it has amended and restated its interim management discussion and analysis (the "Interim MD&A") for the three and nine months ending December 31, 2019. The Interim MD&A has been amended to clarify and expand upon the qualitative discussion...

    2020-05-29 4:30 PM ET
  • BioMark's Liquid Biopsy Assay Levering Metabolomics Demonstrates Strong Performance for Early Lung Cancer Detection

    Vancouver, British Columbia--(Newsfile Corp. - March 24, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC PINK: BMKDF) ("BioMark") is pleased to announce that the article "A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection" has been published in the peer-reviewed journal Cancers, validating BioMark's technology to detect early-stage (I/II) non-small cell lung cancer (NSCLC) using a simple blood plasma test.Rashid Bux, President and CEO, says, "This latest publication demonstrates our ability to further leverage our international team...

    2020-03-24 6:30 AM ET
  • BioMark Diagnostics Advanced Raman Spectrometer Could Potentially Serve as Complementary Detection Tool for COVID -19 / Coronavirus

    Vancouver, British Columbia--(Newsfile Corp. - March 16, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-invasive, and accurate diagnostic solutions which can help detect, monitor and assess cancer early and cost effectively, announced today following their annual technology meeting that their Advanced Raman Spectrometer might have potential to be modified and reconfigured for use in the detection of certain pathogens and mutations within the COVID-19, Coronavirus. BioMark's Raman Spectrometer...

    2020-03-16 8:30 AM ET